Health Archive » June, 2008

Health - June, 2008

146 articles

• Health Care Practice: Holland & Knight
• Wyeth Sues Biovail Over ANDA For Effexor
• Par Pharma Shareholders Seek Settlement Approval
• Roche Drops Patent Claims Over Boniva
• Nossaman Merges With D.C. Firm
• Bill Would Bar Felons From Seeking FDA's OK
• Canada Court Refuses To Toss Wyeth Premarin Case
• Medical Device Act Would Restore State Remedies
• Boehringer's Mirapex Patent Declared Invalid
• Body Parts Mastermind Sentenced To 18-54 Years
• Eli Lilly, Princeton Lodge 2nd Suit Over Chemo Drug
• Walgreen Drops Case Against ABP Over Label Patents
• Judge Strips Claims From Wage Suit Against Insurer
• ABLSA, AmeriPath Settle Diagnostic Patent Spat
• Court Certifies Pharmacy Class In AWP Suit V. Eckerd
• European Regulators Warn Of Anemia Drug Risks
• Quintiles Sued Over Drug Data Collection Patent
• Pfizer's Lipitor Patent Invalidated In South Korea
• Groups Try To Block AIDS Drug Patent In India
• Exxon Ruling Will Drill Punitive Awards: Experts
• Health Care Practice: Skadden Arps
• Acacia Unit Settles Patent Claims With Siemens
• Judge Approves Settlement In Eating Disorder Case
• Melnyk Goes To Court To Fight Biovail Vote
• Court Rules Abbott Glucose Strip Patent Invalid
• Orthopedic Co. Brings Patent Suit Against Aussie Rival
• Judge Gives Par Pharma Shareholders 2nd Chance
• Health Care Practice: Morgan Lewis
• C&D Scores $29M In Doubled Damages From Abbott
• Ex-Biomet Distributor Claims Trade Secrets Breach
• Pfizer To Pay $975,000 For Clean Air Act Violations
• Seroquel Plaintiffs Must Turn Over Zyprexa Info
• Connetics, Agis Settle Suit Over Scalp Treatment
• Vision Care Rivals Ink Patent Cross-Licensing Deal
• Gender Bias Plaintiffs Fight Sanofi's Subpoenas
• Pregnancy Discrimination Not Covered By Fla. Law
• Ex-Biovail CFO Blasts SEC Over Complaint
• Firm Fights For Fee Payout In Medtronic MDL
• FDA Panel To Review Safety Of Contrast Agent
• Bio-Rad Sues Over Cell DNA Absorption Patents
• Wyeth, Cordis Dismiss Boston Scientific Stent Suit
• Judge Closes Merck Derivative Suit Over Vioxx
• FDA Committee OKs Psoriasis Drug For Kids
• Allison Engine: The Presentment Issue Under The FCA
• AstraZeneca Will Appeal Alabama Medicaid Ruling
• Court Sides With Fund Partners In Shareholder Suit
• Justice Dept.'s Paxil Investigation Gets Wider
• White House Settles Suit Over Medicare, Medicaid
• Pfizer Ignored Neurontin Suicide Link: Testimony
• FDA Broadens Unsafe OTC Drug List
• U. Of Pittsburgh Owns Stem Cell Patent: Judge
• Calif. Bill To Sell Prescription Info Defeated
• Suppliers Sued In Duke Hospital Contamination
• N.Y. Court Moves Out-Of-State Plaintiff's Lipitor Case
• Medtronic Judge OKs Protocol For Attorneys' Fees
• FDA Warns Companies That Sell Fake Cancer Cures
• Pfizer Settles Lipitor Battles With Ranbaxy
• University Tries New Venue In Suit Against Varian
• Pfizer Loses Bid To Toss Overtime Suit By Sales Reps
• Medical Device Co. Wins $1.1M, Eyes Injunction
• BIPI Withheld Mirapex Study: Plaintiffs' Lawyer
• Inequitable Conduct Ruling Against Synthon Upheld
• Elan Wins $55M From Abraxis In Cancer Drug Suit
• FDA Exacts Tougher Labels For Anti-Psychotic Drugs
• Federal Circuit Revives Patent Correction Suit, Again
• Fed. Circuit Boots Fee Award Back To Lower Court
• FDA Generic Drug Reviews Routinely Delayed: Study
• J&J Psoriasis Drug Might Pose Risk: FDA Staff
• Sanofi Asserts 2nd Uroxatral Patent Against Sun
• Celgene Loses Bid To Stay Claims In Thalomid Suit
• Sandoz Sued By Sepracor, UCB Over Allergy Drug
• Biopharma Co. Maxygen Fears Amgen Might Sue
• Wyeth Sues Again Over Protonix Patent
• When Negotiation Amounts To Price-Fixing
• Stryker Faces Yet Another Suit Over Pain Pump
• Facing $14.7M Judgment, Arthrex Sued Again
• Hernia Plaintiff Asks For Sanctions After Mediation
• Medical Monitoring: Gone With The '90s?
• Sen. Grassley Calls For FDA Probe Of Paxil
• Janssen Sues Sandoz Over Alzheimer's Drug ANDA
• Judge OKs $400M Sale Of Leiner Assets To NBTY
• Proceed With Caution In Restricting Union Buttons
• Oregon Judges Side With Medical Marijuana User
• N.Y. AG To Sue Drugstore Chains Over Old Goods
• Jury Orders Arthrex To Pay $14M For Infringement
• Pro-Union Group Protests Outside Foley & Lardner
• Genentech, MedImmune Settle Synagis Patent Spat
• UnitedHealth Execs Knew About Backdating: Report
• Takeda, Ethypharm Sue Barr Over Prevacid
• SEC Launches FCPA Investigation Into Wright Medical
• Lawyer Demands Warnings On Herbalife Products
• Metabolife CEO Gets 6 Months For Misleading FDA
• Wyeth Calls For Ousting Of Lawyers In Prempro MDL
• Vioxx Rulings Could Bode Ill For N.J. Class Actions
• AstraZeneca Asks Ala. Court To Toss $215M Verdict
• AstraZeneca Loses Bid To Overturn Prilosec Ruling
• Facing FTC Challenge, Hospitals Drop Merger Plans
• Vitamin C MDL Defendants Renew Call To Dismiss
• White House Increases Funding Request For FDA
• Ethex Recalls Certain Morphine Tablets
• AWP Judge Sends Utah Complaint Back To State Court
• Texas Law Limits Makers' Duty To Defend: 5th Circ.
• Catheter Maker Rounds Up Rivals In Patent Suit
• Life Sciences Cos. Face More Shareholder Suits
• Heparin-Related Deaths Continue To Climb
• J&J's Regranex Ups Cancer Mortality Risk: FDA
• Drug Cos. Protest Utah's Bid To Remove AWP Case
• Judge Nixes AWP Plaintiffs' Appeal For Class Counsel
• Wyeth Gets Federal Backing In Preemption Case
• Lupin Seeks To Preempt Claim Over Ramipril Patent
• Merck Must Turn Over Docs In Fosamax MDL: Judge
• Dr. Reddy's Tries To Nip New Nexium Spat In The Bud
• Heller Ehrman Shareholder Moves To Cooley IP Group
• Firm Takes Aim At Fen-Phen Client For Defamation
• Wellpoint Loses Bid To Block 8 Missouri Plaintiffs
• Fresenius Wins New Election In Union Spat
• Bay Area Exec Sues Kaiser For AIDS Discrimination
• Mylan, Abbott Bury Hatchet Over Depakote ER
• FDA Settles Lawsuit Over Mercury In Dental Fillings
• FDA Probes Drugs' Link To Cancer In Children
• FDA Ponders Changes To Lens Solution Regulations
• Judge Tosses AstraZeneca Suit Over Blood Thinner
• Walgreens To Fork Over $35M In Medicaid Fraud Suit
• N.J. High Court Reinstates Dismissal Of Vioxx Suit
• Aredia Plaintiffs Say Cancer Doctor Must Testify
• SEC Nabs 2 For Trading On Insider J&J Merger Info
• FDA Links Suicide And Epilepsy Drugs
• Off-Label Marketing On Shaky Ground
• FTC Approves Comments On Illinois Retail Clinic Law
• Pharma Execs To Be Videotaped At FTC Hearing
• Mylan Sued Over Blood Pressure Drug
• Anti-Obesity Drug Linked To 5 Deaths In U.K.
• Plaintiff Fights Aetna Deal On Anorexia Benefits
• High Court Rejects Apotex Fraud Case Against Merck
• Cephalon Sues Watson To Block Generic Fentora
• Guidant Plaintiffs Attorneys May Not Withdraw: Judge
• Dalkon Shield Plaintiff's Malpractice Claims Remanded
• VNUS To Reap $10M In Patent Settlement
• Bayer's Trasylol Increases Risk Of Death: Study
• Misconduct Testimony Allowed In Pfizer Age Bias Suit
• Abbott Recalls Low-Calcium Baby Formula
• Fed. Circ. Naysays Fresenius Bid For Injunction Stay
• Sanofi Illegally Blocked Inspectors During Raid: EC
• Lilly Moves Zyprexa Suit To Federal Court
• No IP Info For Protonix Antitrust Plaintiffs: Judge
• Studies, Senator Prompt FDA To Look At Chantix